Hormone Testing & HRT

Comprehensive hormone panel testing and bioidentical hormone replacement therapy (BHRT) at Elysium Aesthetics + Longevity in Chicago. Includes full lab assessment for hormone levels followed by a personalised HRT protocol delivered via subcutaneous pellets, injectables, topical creams, or oral tablets. Protocol results typically noticeable within four to six weeks. Supervised by Medical Director Dr. Mick I. Singh MD.

Elysium Aesthetics + Longevity offers a structured hormone optimisation programme that begins with a comprehensive hormone panel blood draw to baseline the patient's current endocrine status. The panel typically encompasses sex hormones (estradiol, testosterone — total and free — DHEA-S, progesterone), adrenal markers (cortisol), thyroid function (TSH, free T3, free T4), and metabolic indicators (fasting insulin, glucose, HbA1c) depending on the patient profile. This data-driven approach is central to the clinic's longevity positioning — rather than treating symptoms empirically, the protocol is calibrated to each patient's lab values, symptoms, age, and health history. Bioidentical hormone replacement therapy (BHRT) delivery options at Elysium span the full spectrum of administration routes: subcutaneous pellets (implanted under the skin every three to six months for sustained-release delivery), intramuscular or subcutaneous injectables (self-administered or clinic-administered on a weekly or biweekly basis), topical creams and gels (daily application, fast to adjust dosing), and oral tablets or sublingual troches. The choice of delivery method is determined by the patient's lifestyle, compliance preference, and the specific hormones being replaced. Testosterone optimisation for male patients (low-T protocols) and estrogen/progesterone balancing for perimenopausal and postmenopausal women are the most common programmes. Patients typically begin noticing improvements in energy, mood, libido, sleep quality, and body composition within four to six weeks of initiating treatment, with continued optimisation at follow-up labs three to six months later. All hormone programmes are supervised by Medical Director Dr. Mick I. Singh MD.